| 000 | 01533 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515004345.0 | ||
| 264 | 0 | _c20061214 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0022-3573 | ||
| 024 | 7 |
_a10.1211/jpp.57.11.0005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDon, Burl R | |
| 245 | 0 | 0 |
_aThe pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacy and pharmacology _cNov 2005 |
||
| 300 |
_a1407-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPharmacokinetics |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xadministration & dosage |
| 650 | 0 | 4 | _aRenal Dialysis |
| 700 | 1 | _aSpin, Gregory | |
| 700 | 1 | _aNestorov, Ivan | |
| 700 | 1 | _aHutmacher, Matt | |
| 700 | 1 | _aRose, Aubri | |
| 700 | 1 | _aKaysen, George A | |
| 773 | 0 |
_tThe Journal of pharmacy and pharmacology _gvol. 57 _gno. 11 _gp. 1407-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1211/jpp.57.11.0005 _zAvailable from publisher's website |
| 999 |
_c15886532 _d15886532 |
||